AnnouncementsGlaxoSmithKline Pharmaceuticalss AGM on April 17, 2014
AnnouncementsGSK Pharmaceuticals: Updates on open offer
No recommendations so far.What's your call on GlaxoSmithKline today? Read 7 investor views
|Company Name||Last Price||%
|Dr Reddys Labs||2539.35||-1.48||2939.80||1904.15||43,196.60|
|Dec' 13||Sep' 13||Jun' 13||Mar' 13|
GlaxoSmithKline is in the Pharmaceuticals sector. The current market capitalisation stands at Rs 21,244.36 crore.The company has reported a standalone sales of Rs 630.63 crore and a Net Profit of Rs 116.88 crore for the quarter ended Dec 2013.
The company management includes D S Parekh - Chairman, V Thyagarajan - Vice Chairman, H B Joshipura - Managing Director, R R Bajaaj - Director, A Bansal - Director, P V Bhide - Director, S Harford - Director, M B Kapadia - Director, N Kaviratne CBE - Director, R Krishnaswamy - Director, P V Nayak - Director, A N Roy - Director, R C Sequeira - Director, D Sundaram - Director.
It is listed on the BSE with a BSE Code of 500660 and the NSE with an NSE Code of GLAXO.
Its Registered office is at Dr. Annie Besant Road , Mumbai,Maharashtra - 400030.
Their Registrars are Karvy Computershare Private Ltd.